tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Cynata Therapeutics Forms New Scientific Advisory Board to Enhance R&D Strategy
Company AnnouncementsCynata Therapeutics Forms New Scientific Advisory Board to Enhance R&D Strategy
7d ago
Cynata’s Cymerus™ MSCs Show Promise in Heart Disease Treatment
PremiumCompany Announcements
Cynata’s Cymerus™ MSCs Show Promise in Heart Disease Treatment
14d ago
Cynata Therapeutics Updates Director’s Interest Notice
PremiumCompany Announcements
Cynata Therapeutics Updates Director’s Interest Notice
20d ago
Cynata Therapeutics Showcases at Advanced Therapies Congress 2025
PremiumCompany Announcements
Cynata Therapeutics Showcases at Advanced Therapies Congress 2025
1M ago
Cynata Therapeutics Engages Investors at Euroz Hartleys Conference
PremiumCompany Announcements
Cynata Therapeutics Engages Investors at Euroz Hartleys Conference
1M ago
Cynata Therapeutics Reports Financial Results for Half-Year Ending December 2024
PremiumCompany AnnouncementsCynata Therapeutics Reports Financial Results for Half-Year Ending December 2024
2M ago
Cynata Therapeutics Announces Expiry of CYPOA Options
Premium
Company Announcements
Cynata Therapeutics Announces Expiry of CYPOA Options
2M ago
Cynata Therapeutics Director Updates Securities Holdings
Premium
Company Announcements
Cynata Therapeutics Director Updates Securities Holdings
2M ago
Cynata Therapeutics Issues New Securities to Boost Market Position
PremiumCompany Announcements
Cynata Therapeutics Issues New Securities to Boost Market Position
2M ago
Cynata Therapeutics to Host Investor Webinar on Clinical Advancements
PremiumCompany Announcements
Cynata Therapeutics to Host Investor Webinar on Clinical Advancements
2M ago
Cynata’s iPSC-derived MSCs Show Superior Therapeutic Potential
PremiumCompany Announcements
Cynata’s iPSC-derived MSCs Show Superior Therapeutic Potential
3M ago
Cynata Therapeutics to Showcase Cymerus™ Technology at Euroz Hartleys Forum
PremiumCompany Announcements
Cynata Therapeutics to Showcase Cymerus™ Technology at Euroz Hartleys Forum
3M ago
Cynata Therapeutics Advances Clinical Trials and Strengthens Financial Position
PremiumCompany AnnouncementsCynata Therapeutics Advances Clinical Trials and Strengthens Financial Position
3M ago
Cynata Therapeutics Announces Director’s Increase in Shareholding
Premium
Company Announcements
Cynata Therapeutics Announces Director’s Increase in Shareholding
3M ago
Cynata Therapeutics Issues Shares to Directors Post-Approval
Premium
Company Announcements
Cynata Therapeutics Issues Shares to Directors Post-Approval
3M ago
Cynata Therapeutics Expands Market Presence with New Securities Quotation
PremiumCompany Announcements
Cynata Therapeutics Expands Market Presence with New Securities Quotation
3M ago
Cynata Therapeutics Successfully Concludes Extraordinary General Meeting
PremiumCompany Announcements
Cynata Therapeutics Successfully Concludes Extraordinary General Meeting
3M ago
Cynata Therapeutics to Present at Biotech Showcase™
PremiumCompany Announcements
Cynata Therapeutics to Present at Biotech Showcase™
3M ago
Cynata Therapeutics Sees Change in Substantial Shareholder Voting Power
PremiumCompany Announcements
Cynata Therapeutics Sees Change in Substantial Shareholder Voting Power
4M ago
Cynata Therapeutics Announces Key Shareholder Meeting and Trial Updates
PremiumCompany AnnouncementsCynata Therapeutics Announces Key Shareholder Meeting and Trial Updates
4M ago
Cynata Therapeutics Raises $8.1M After Positive Trial Results
Premium
Company Announcements
Cynata Therapeutics Raises $8.1M After Positive Trial Results
5M ago
Cynata’s CYP-006TK Shows Promise in Diabetic Foot Ulcer Trial
Premium
Company Announcements
Cynata’s CYP-006TK Shows Promise in Diabetic Foot Ulcer Trial
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >